BL Pharmtech Corp. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was KRW 0.00001 million compared to KRW 0.00001 million a year ago.

Net loss was KRW 148.85 million compared to KRW 13,903.07 million a year ago. Basic loss per share from continuing operations was KRW 155 compared to KRW 162 a year ago. Basic loss per share was KRW 1 compared to KRW 156 a year ago.